Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
From Benzinga
Alnylam Hits Pfizer, Moderna With Patent Infringement Suits
March 17, 2022
From Benzinga
Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron
March 17, 2022
From Benzinga
Why Eiger BioPharmaceuticals Stock Is Jumping Today
March 17, 2022
From Benzinga
From Benzinga
From Benzinga
WHO Foundation Warns Global Economy To Lose "Trillions Of Dollars" On COVID-19 Vaccine Inequality: CNBC
March 16, 2022
From Benzinga
From Benzinga
From Benzinga
Immunoprecise, Elektrofi To Pursue Low-Volume Injectable Formulation Of IPA's COVID-19 Antibody Cocktail
March 14, 2022
Tickers
IPA
From Benzinga
Pfizer-BioNTech's COVID-19 Shot Moderately Effective Against Omicron In Kids Aged 5 to 15, CDC Study Shows
March 14, 2022
From Benzinga
GSK/Vir Biotech's COVID-19 Antibody Associated With Resistance Mutations, New Research Shows
March 11, 2022
From Benzinga
FDA Lifts Clinical Hold on Immunome's COVID-19 Candidate IND
March 11, 2022
Tickers
IMNM
From Benzinga
Oragenics Partners With KBI Biopharma To Produce Material For Its Intranasal COVID-19 Vaccine Candidate
March 10, 2022
Tickers
OGEN
From Benzinga
From Benzinga
Novavax's COVID-19 Shot Inches Up To FDA Authorization: WSJ
March 07, 2022
Tickers
NVAX
From Benzinga
From Benzinga
Pfizer Commits 10M Courses Of COVID-19 Oral Antiviral To Developing Countries: Reuters
March 03, 2022
Tickers
PFE
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free